Trial ID 21271 | Maryland Oncology Hematology Trial ID 21271 – Maryland Oncology Hematology

Trial ID 21271

Trial Information - Phase II

A Phase 2 Open-Label, Multicenter Study to Evaluate Efficacy and Safety of ZN-c3 in Adult Women with Recurrent or Persistent Uterine Serous Carcinoma

Protocol ID: ZN-c3-004 | GOG 3065

Sponsor: GOG Foundation/K-Group Beta, Inc/Zentalis Pharmaceuticals

Status: PENDING OPEN

Contact us regarding Clinical Trials at MOHRSCH@usoncology.com
or call us at 877-664-7724

Disease Types

Uterine

Investigator

Werner MD, Jeanine

Status

PENDING OPEN

Sponsor

GOG Foundation/K-Group Beta, Inc/Zentalis Pharmaceuticals

Quality Care Close to Home


View our locations on map!

Sign Up Today For Our E-Newsletter

  • This field is for validation purposes and should be left unchanged.
United in Healing with The US Oncology Network - Maryland Oncology Hematology